Tertatolol
![]()  | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names | 
| Routes of administration  | Oral | 
| ATC code | |
| Legal status | |
| Legal status | 
  | 
| Identifiers | |
IUPAC name 
  | |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | 
  | 
| UNII | |
| KEGG | 
  | 
| ChEMBL | |
| ECHA InfoCard | 100.073.179 | 
| Chemical and physical data | |
| Formula | C16H25NO2S | 
| Molar mass | 295.44 g·mol−1 | 
| 3D model (JSmol) | |
| Chirality | Racemic mixture | 
SMILES 
  | |
InChI 
  | |
|   | |
Tertatolol (Artex, Artexal, Prenalex) is a medication in the class of beta blockers, used in the treatment of high blood pressure. It was discovered by the French pharmaceutical company Servier and is marketed in Europe.[1]
Tertatolol has also been shown to act as a serotonin 5-HT1A and 5-HT1B receptor antagonist, similarly to propranolol and pindolol.[2][3][4]
See also
References
- ↑ Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. ISBN 3-88763-075-0.
 - ↑ Langlois M, Brémont B, Rousselle D, Gaudy F (January 1993). "Structural analysis by the comparative molecular field analysis method of the affinity of beta-adrenoreceptor blocking agents for 5-HT1A and 5-HT1B receptors". European Journal of Pharmacology. 244 (1): 77–87. doi:10.1016/0922-4106(93)90061-d. PMID 8093601.
 - ↑ Jolas T, Haj-Dahmane S, Lanfumey L, Fattaccini CM, Kidd EJ, Adrien J, et al. (May 1993). "(-)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain". Naunyn-Schmiedeberg's Archives of Pharmacology. 347 (5): 453–463. doi:10.1007/bf00166735. PMID 7686633. S2CID 22129922.
 - ↑ van Wijngaarden I, Soudijn W, Tulp MT (1997). "5-HT1A Receptors". In Soudijn W, Olivier B, van Wijngaarden I (eds.). Serotonin Receptors and Their Ligands. Amsterdam: Elsevier. ISBN 0-444-82041-8.
 
| β, non-selective | |
|---|---|
| β1-selective | |
| β2-selective | |
| α1- + β-selective | |
  | |
Serotonin receptor modulators  | |||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5-HT1 | 
  | ||||||||||||||||||||||||||||||||||||||
| 5-HT2 | 
  | ||||||||||||||||||||||||||||||||||||||
| 5-HT3–7 | 
  | ||||||||||||||||||||||||||||||||||||||
  | |||||||||||||||||||||||||||||||||||||||
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
